GOVX @ .08, 42M float. Now has most advanced HIV vaccine. The company market cap is $3.5M dollars. It is 9.5% owned by Emory University & being funded by the CDC and the NIH. GOVX HIV vaccine news is major in every way and puts GOVX is the top rank of vaccine platys right now. Also, a major buyout target as well. LINK: http://www.marketwired.com/press-release/geovax-hiv-vaccine-clinical-data-presented-at-hivr4p-conference-2168583.htm